PCN402 THE CLINICAL AND ECONOMIC CONSEQUENCES OF DELAYS IN REIMBURSEMENT FOR SELECT NOVEL CANCER THERAPEUTICS IN CANADA, ITALY, AND AUSTRALIA
Abstract
Authors
B. Leinwand J. Sollano J.P. Doherty G. Smith F. Ali M. Johnsrud T. Abdelgawad S. Kamal-Bahl D. Munch G. Makinson